Article Information
History
- July 29, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Cecilie Bo Hansen1,Ψ,
- Ida Jarlhelt1,Ψ,
- Laura Pérez-Alós1,Ψ,
- Lone Hummelshøj Landsy2,
- Mette Loftager2,
- Anne Rosbjerg1,
- Charlotte Helgstrand3,
- Jais Rose Bjelke3,
- Thomas Egebjerg3,
- Joseph G. Jardine4,
- Charlotte Sværke Jørgensen5,
- Kasper Iversen6,
- Rafael Bayarri-Olmos1,ǂ,
- Peter Garred1,ǂ and
- Mikkel-Ole Skjoedt1,7,ǂ,*
- 1Laboratory of Molecular Medicine, Department of Clinical Immunology, Section 7631, Rigshospitalet, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
- 2Department of Non-Clinical & Clinical Assay Sciences, Global Discovery & Development Sciences, Novo Nordisk A/S, Måløv, Denmark
- 3Recombinant Technologies, Novo Nordisk A/S, Måløv, Denmark
- 4IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037, USA
- 5Department of Microbiological Diagnostics & Virology, Statens Serum Institut, Copenhagen, Denmark
- 6Department of Cardiology, Herlev University Hospital, Herlev, Denmark
- 7Institute of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark
- ↵*Corresponding author: Dr. Mikkel-Ole Skjoedt, Laboratory of Molecular Medicine, Department of Clinical Immunology, Section 7631, Rigshospitalet, University Hospital of Copenhagen, Ole Maaløes Vej 26, 2200 Copenhagen, Denmark. Telephone: +45 35457719. Email: moskjoedt{at}sund.ku.dk